Breaking News Instant updates and real-time market news.

XLNX

Xilinx

$81.01

1.05 (1.31%)

12:05
10/02/18
10/02
12:05
10/02/18
12:05

Xilinx unveils Versal,delivering 'innovation' with software programmability

Xilinx Developer Forum - Enabling a new era of rapid innovation for any application by any developer, Xilinx, CEO Victor Peng unveiled Versal - the industry's first adaptive compute acceleration platform. Versal ACAPs combine Scalar Processing Engines, Adaptable Hardware Engines, and Intelligent Engines with leading-edge memory and interfacing technologies to deliver powerful heterogeneous acceleration for any application. But most importantly, the Versal ACAP's hardware and software can be programmed and optimized by software developers, data scientists, and hardware developers alike, enabled by a host of tools, software, libraries, IP, middleware, and frameworks that enable industry-standard design flows.

XLNX Xilinx
$81.01

1.05 (1.31%)

09/07/18
COWN
09/07/18
INITIATION
Target $81
COWN
Market Perform
Xilinx initiated with a Market Perform at Cowen
Cowen analyst Matthew Ramsay initiated Xilinx with a Market Perform rating as he believes the risk/reward is balanced at current levels given the stock's premium valuation. He told investors he was waiting for more tangible signs of traction against a compelling datacenter opportunity before recommending the shares. Ramsay has a $81 price target on Xilinx shares.
09/27/18
NEED
09/27/18
INITIATION
NEED
Buy
Xilinx initiated with a Buy at Needham
09/27/18
NEED
09/27/18
INITIATION
Target $100
NEED
Buy
Xilinx initiated with a Buy at Needham
As reported earlier, Needham analyst N. Quinn Bolton initiated Xilinx with a Buy rating and a price target of $100. The analyst says the company invented the field-programmable gate array, or the FPGA, and today it is the largest vendor of this technology that is "entering a new growth phase driven by the adoption of accelerated computing". Bolton expects Xilinx to drive share gains in the data center market and is also positive on its position in the emerging 5G wireless network development, expecting these opportunities to produce accelerated revenue growth over the next several years.
10/01/18
BOFA
10/01/18
NO CHANGE
Target $95
BOFA
Buy
Xilinx price target raised to $95 from $85 at BofA/Merrill
BofA/Merrill analyst Vivek Arya raised his price target on Xilinx to $95 and kept his Buy rating ahead of this week's 2nd annual Developer Forum hosted by the company. The analyst says Xilinx could offer a "positive" update with a potential "customer and/or product announcements related to the initial production of its new Project Everest chip for data center accelerator boards". While he does not anticipate any financial updates in the wake of its recent Analyst Day projections, Arya notes that Xilinx could also offer more detail around its data center opportunity after indicating that its acceleration boards may contribute to data center sales doubling to $500M-600M in sales.

TODAY'S FREE FLY STORIES

CSLT

Castlight Health

$2.62

0.04 (1.55%)

09:15
10/18/18
10/18
09:15
10/18/18
09:15
Recommendations
Castlight Health analyst commentary  »

William Blair sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

DTRM

Determine

$0.58

-0.01 (-1.69%)

09:14
10/18/18
10/18
09:14
10/18/18
09:14
Hot Stocks
GTT choses Determine's procure-to-pay solution »

Determine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PACW

PacWest Bancorp

$44.20

-0.14 (-0.32%)

09:13
10/18/18
10/18
09:13
10/18/18
09:13
Recommendations
PacWest Bancorp analyst commentary  »

PacWest Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

PM

Philip Morris

$84.62

1.12 (1.34%)

09:13
10/18/18
10/18
09:13
10/18/18
09:13
Hot Stocks
Philip Morris says KFDA comments impacting those new to IQOS »

Says KFDA comments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ATOM

Atomera

$4.65

(0.00%)

09:12
10/18/18
10/18
09:12
10/18/18
09:12
Initiation
Atomera initiated  »

Atomera initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

CGIX

Cancer Genetics

$0.82

0.01 (1.23%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
Cancer Genetics enters strategic partnership with Genecast Biotechnology »

Cancer Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BL

BlackLine

$45.55

-0.01 (-0.02%)

, TRUE

TrueCar

$12.14

-0.1 (-0.82%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
BlackLine names Susan Otto as chief people officer »

BlackLine (BL) announced…

BL

BlackLine

$45.55

-0.01 (-0.02%)

TRUE

TrueCar

$12.14

-0.1 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 13

    Nov

CCB

Coastal Financial

$16.25

0.05 (0.31%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
Coastal Financial hires Erika Heer as CHRO »

Coastal Financial hired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
10/18/18
10/18
09:10
10/18/18
09:10
General news
Fed dove Bullard said monetary policy is about right »

Fed dove Bullard said…

09:10
10/18/18
10/18
09:10
10/18/18
09:10
General news
The Philly Fed slipped to 22.2 »

The Philly Fed slipped to…

SPN

Superior Energy

$9.62

-0.25 (-2.53%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PM

Philip Morris

$84.62

1.12 (1.34%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Hot Stocks
Philip Morris sees Q4 net revenue down about 5%, reflecting difficult comps »

Says September YTD net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

IBM

IBM

$134.05

-10.97 (-7.56%)

, LNVGY

Lenovo

$0.00

(0.00%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Hot Stocks
IBM signs $240M agreement with Lenovo for AI call center technology »

IBM (IBM) will supply…

IBM

IBM

$134.05

-10.97 (-7.56%)

LNVGY

Lenovo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 13

    Nov

  • 03

    Mar

TMO

Thermo Fisher

$234.64

-0.59 (-0.25%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Thermo Fisher rating change  »

Thermo Fisher downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 24

    Oct

HAL

Halliburton

$39.56

-0.52 (-1.30%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Halliburton rating change  »

Halliburton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

STIM

Neuronetics

$22.50

-1.63 (-6.76%)

09:07
10/18/18
10/18
09:07
10/18/18
09:07
Recommendations
Neuronetics analyst commentary  »

Neuronetics fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

KEY

KeyCorp

$18.75

0.17 (0.91%)

09:07
10/18/18
10/18
09:07
10/18/18
09:07
Hot Stocks
KeyCorp sees Q4 average loans up low single digits »

Sees Q4 average deposits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 30

    Oct

  • 16

    Nov

SAN

Banco Santander

$4.90

-0.085 (-1.71%)

09:07
10/18/18
10/18
09:07
10/18/18
09:07
Periodicals
German probe into share-swapping scheme spreads to Santander, FT reports »

Spain's Banco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$202.78

0.48 (0.24%)

09:05
10/18/18
10/18
09:05
10/18/18
09:05
Hot Stocks
Amgen invests $66M in Oxford Nanopore Technologies »

Amgen announced an equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 30

    Oct

  • 07

    Nov

  • 09

    Nov

FLS

Flowserve

$51.52

-0.29 (-0.56%)

09:04
10/18/18
10/18
09:04
10/18/18
09:04
Downgrade
Flowserve rating change  »

Flowserve downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XYL

Xylem

$71.34

-0.4 (-0.56%)

09:04
10/18/18
10/18
09:04
10/18/18
09:04
Upgrade
Xylem rating change  »

Xylem upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

PNFP

Pinnacle Financial

$56.63

1.43 (2.59%)

09:04
10/18/18
10/18
09:04
10/18/18
09:04
Recommendations
Pinnacle Financial analyst commentary  »

Pinnacle Financial price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 26

    Nov

NUE

Nucor

$59.11

0.17 (0.29%)

09:04
10/18/18
10/18
09:04
10/18/18
09:04
Earnings
Breaking Earnings news story on Nucor »

Nucor reports Q3 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

NUE

Nucor

$59.11

0.17 (0.29%)

09:03
10/18/18
10/18
09:03
10/18/18
09:03
Hot Stocks
Nucor CEO: We are on pace for 2018 to be a record year for earnings »

"The strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

NUE

Nucor

$59.11

0.17 (0.29%)

09:03
10/18/18
10/18
09:03
10/18/18
09:03
Earnings
Nucor expects Q4 earnings to 'decrease across all three operating segments' »

Q4 EPS consensus $2.08.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.